Featured Research

from universities, journals, and other organizations

Lung cancer metastasis: Researchers find key component -- and possible way to block it

Date:
March 15, 2011
Source:
University of Texas M. D. Anderson Cancer Center
Summary:
Researchers have discovered a new, key component in the spread of lung cancer as well as a likely way to block it with drugs now in clinical trial.

Researchers discovered a new, key component in the spread of lung cancer as well as a likely way to block it with drugs now in clinical trial.

Related Articles


The study was published in the Journal of Clinical Investigation.

A team led by scientists at The University of Texas MD Anderson Cancer Center found a way to identify metastasis-prone lung cancer cells and then uncovered a mechanism that shifts primary tumor cells into a more deadly type of cell with the capacity to move elsewhere in the body.

"We think tumors have to learn how to metastasize because they can't do it initially," said paper senior author Jonathan Kurie, M.D., professor in MD Anderson's Department of Thoracic/Head and Neck Medical Oncology. "Cells change in response to cues from their external environment."

About 90 percent of all cancer deaths are caused by metastasis -- the spread to, and invasion of, other organs. Lung cancer is the leading cause of cancer-related death in the United States, accounting for more than 157,000 deaths annually. The median five-year survival rate is 3.5%

Jagged2 silences protective microRNA

The researchers found that when a protein called Jagged2 binds externally to Notch, a membrane protein that sticks out through the surface of a cell, it suppresses a microRNA that thwarts metastasis inside the cell.

"Jagged2 suppresses miR-200 and drives metastasis as a consequence." Kurie said. "It's been known for some time that Notch is involved in cancer, but no one really knew how."

Two Notch inhibitors are in clinical trial at MD Anderson. "These drugs might suppress the ability of primary tumors to metastasize," Kurie said.

"One question is who is supposed to get these drugs," Kurie said. "Our data suggest that low levels of miR-200 may indicate a tumor's susceptibility to Notch inhibitors."

Jailing tumor cells

While the drugs don't kill a primary tumor, they do "keep the primary lung tumors in jail," holding them in place and blocking their transition to mobile cells, Kurie said.

This transition, from immobile epithelial cells, which line or cover an organ, to a migratory cell with the properties of a mesenchymal cell, is an early event in metastasis. Kurie and colleagues previously showed that miR-200 blocks this epithelial-to-mesenchymal transition. About 80 percent of all cancers begin in the epithelial cells of organs.

Telltale surface protein identifies metastatic cells

The first crucial research step was to identify and study non-small cell lung cancer cells prone to metastasizing.

Yanan Yang, Ph.D., study first author and a postdoctoral fellow in Kurie's lab, studied lung cancer cells in mice, searching for markers of metastasis. He homed in on a surface protein called CD133.

"In primary lung tumors, CD133 cells are under 1 percent of cells," Yang said. "In metastatic lesions, more than 80 percent of the cells have CD133."

Follow up studies determined that CD133-expressing cells were located on the perimeter of tumors, ideally situated for metastasis. More than half of mice injected with CD133-positive lung cancer cells had metastatic cancer, compared to less than 20 percent of those injected with CD133-negative cells.

Intensive study of CD133 metastatic cells revealed that they highly expressed Notch ligands (proteins that bind to specific receptors on other cells). Yang said they separately depleted two Notch ligands -- Jagged1 and Jagged2 -- from tumor cells. Removing Jagged1 had no effect, but cells with little Jagged2 did not metastasize.

"Because epithelial-to-mesenchymal transition (EMT) is a very early step in metastasis," Yang said, "we thought Jagged2 might regulate EMT." When they knocked down Jagged2 again, they found levels of the EMT-stifling miR-200 increased.

External signals drive change

Additional research found that Jagged2 reduced miR-200 by tipping a delicate balance between the microRNA and a protein called GATA3, which inhibit one another. Stimulating production of more GATA3 reduced levels of miR-200.

"Jagged2 increases the levels of GATA3, which in turn binds to the promoter of miR-200 and suppresses production of miR-200," Yang said.

"The study is among the first to show that mir-200 is regulated by specific signals emanating from the environment surrounding cancer cells. These signals are keys to understanding metastasis," Yang said.

One surprise, Kurie said, is that GATA proteins had been thought to suppress tumors. "In this case it's exactly the opposite."

The next step is to determine which of the four known Notch receptors suppress miR-200 and promote metastasis. The drugs currently under study are designed to inhibit an enzyme that cleaves and activates all Notch receptors. Drugs that target specific Notch receptors might be more effective inhibitors of metastasis, Kurie said.

Funding for the project was provided by grants from the National Cancer Institute, MD Anderson's Lung Cancer Specialized Program in Research Excellence grant from NCI, the David M. Sather Memorial Fund, The Armour Family Lung Cancer Research Fund, the Dan L. Duncan Cancer Center at Baylor College of Medicine, The ASCO Cancer Foundation, and the International Association for the Study of Lung Cancer.

Co-authors with Yang and Kurie were Young-Ho Ahn, Don L. Gibbons, Yi Zang, Wei Lin, Nishan Thilaganthan, Cristina A. Alvarez, and Daniel C. Moreira, of MD Anderson's Department of Thoracic/Head and Neck Medical Oncology; Moreira also is with the Medical School, Tecnolσgico de Monterrey, Monterrey, Mexico; Chad J. Creighton, Dan L. Duncan Cancer Center, Baylor College of Medicine; and Philip A. Gregory and Gregory J. Goodall of the Centre for Cancer Biology, Hanson Institute, Adelaide, South Australia, Australia, and Discipline of Medicine, University of Adelaide, Adelaide, South Australia, Australia.


Story Source:

The above story is based on materials provided by University of Texas M. D. Anderson Cancer Center. Note: Materials may be edited for content and length.


Journal Reference:

  1. Yanan Yang, Young-Ho Ahn, Don L. Gibbons, Yi Zang, Wei Lin, Nishan Thilaganathan, Cristina A. Alvarez, Daniel C. Moreira, Chad J. Creighton, Philip A. Gregory, Gregory J. Goodall, Jonathan M. Kurie. The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200–dependent pathway in mice. Journal of Clinical Investigation, 2011; DOI: 10.1172/JCI42579

Cite This Page:

University of Texas M. D. Anderson Cancer Center. "Lung cancer metastasis: Researchers find key component -- and possible way to block it." ScienceDaily. ScienceDaily, 15 March 2011. <www.sciencedaily.com/releases/2011/03/110314132347.htm>.
University of Texas M. D. Anderson Cancer Center. (2011, March 15). Lung cancer metastasis: Researchers find key component -- and possible way to block it. ScienceDaily. Retrieved November 24, 2014 from www.sciencedaily.com/releases/2011/03/110314132347.htm
University of Texas M. D. Anderson Cancer Center. "Lung cancer metastasis: Researchers find key component -- and possible way to block it." ScienceDaily. www.sciencedaily.com/releases/2011/03/110314132347.htm (accessed November 24, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Monday, November 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Winter Can Cause Depression — Here's How To Combat It

Winter Can Cause Depression — Here's How To Combat It

Newsy (Nov. 23, 2014) — Millions of American suffer from seasonal depression every year. It can lead to adverse health effects, but there are ways to ease symptoms. Video provided by Newsy
Powered by NewsLook.com
Ebola-Hit Sierra Leone's Late Cocoa Leaves Bitter Taste

Ebola-Hit Sierra Leone's Late Cocoa Leaves Bitter Taste

AFP (Nov. 23, 2014) — The arable district of Kenema in Sierra Leone -- at the centre of the Ebola outbreak in May -- has been under quarantine for three months as the cocoa harvest comes in. Duration: 01:32 Video provided by AFP
Powered by NewsLook.com
Don't Fall For Flu Shot Myths

Don't Fall For Flu Shot Myths

Newsy (Nov. 23, 2014) — Misconceptions abound when it comes to your annual flu shot. Medical experts say most people older than 6 months should get the shot. Video provided by Newsy
Powered by NewsLook.com
WFP: Ebola Risks Heightened Among Women Throughout Africa

WFP: Ebola Risks Heightened Among Women Throughout Africa

AFP (Nov. 21, 2014) — Having children has always been a frightening prospect in Sierra Leone, the world's most dangerous place to give birth, but Ebola has presented an alarming new threat for expectant mothers. Duration: 00:37 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins